Journal Home
Search for

Volume 37, Issue 2, Pages 179-187 (February 2010)


View previous. 10 of 16 View next.

C-kit-targeted imaging of gastrointestinal stromal tumor using radiolabeled anti-c-kit monoclonal antibody in a mouse tumor model

Chizuru Sogawaa, Atsushi B. TsujiaCorresponding Author Informationemail address, Hitomi Sudoab, Aya Sugyoa, Chisato Yoshidaac, Kenichi Odakad, Tomoya Ueharac, Yasushi Aranoc, Mitsuru Koizumia, Tsuneo Sagaa

Received 18 June 2009; received in revised form 28 September 2009; accepted 17 October 2009. published online 30 November 2009.

Abstract 

Introduction

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor arising from the gastrointestinal tract and highly expresses mutated c-kit. We aimed to develop a specific and sensitive method for detecting GISTs using radiolabeled anti-c-kit monoclonal antibody.

Methods

A mutated c-kit-expressing cell clone was established by transfecting an expressing vector of mutated c-kit gene into HEK293 human embryonic kidney cells. The tumors were developed by inoculating c-kit-expressing cells into nude mice. 125I- and 111In-labeled anti-c-kit antibodies (12A8 and 41A11) were evaluated in vitro by cell binding, competitive inhibition and cellular internalization assays, and in vivo by biodistribution and imaging studies in tumor-bearing mice.

Results

Both 125I- and 111In-labeled antibodies showed specific binding with c-kit-expressing cells with high affinity (dissociation constants = 2.2–7.1×109 M−1). Internalization assay showed that 125I-labeled antibodies were rapidly internalized and dehalogenated, with the release of 125I from the cells, resulting in reduction of cell-associated radioactivity with time. In contrast, 111In-labeled antibody was internalized but did not result in the reduced radioactivity associated with tumor cells. Reflecting this phenomenon, the in vivo tumor uptake of 125I-labeled antibody was low on Day 1, further decreasing with time, while tumor uptake of 111In-labeled antibody was high on Day 1, further increasing with time. The xenografted tumor was clearly visualized by scintigraphy after injection of 111In-labeled antibody.

Conclusion

The anti-c-kit monoclonal antibody labeled with a metal radionuclide would be promising for c-kit-targeted imaging of GISTs.

a Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan

b Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo 113-8421, Japan

c Department of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan

d Molecular Probe Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan

Corresponding Author InformationCorresponding author. Tel.: +81 43 206 3429; fax: +81 43 206 0818.

 This research was supported in part by grants from the National Institute of Radiological Sciences and by a Grant-in-Aid for Exploratory Research from Japan Society for the Promotion of Science (No.20659212).

PII: S0969-8051(09)00256-X

doi:10.1016/j.nucmedbio.2009.10.008


View previous. 10 of 16 View next.